Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.790 | ||
| Révision: | $100.14M | $106.97M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.830 | 0.780 | -0.0500 |
| Révision: | $102.16M | $114.78M | $494.00K |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.880 | 0.920 | 0.0400 |
| Révision: | $103.19M | $109.75M | $917.00K |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.940 | 0.750 | -0.1900 |
| Révision: | $105.08M | $101.48M | -$738.00K |
